A Phase I Study of Adagrasib and Durvalumab for Treatment of Advanced Non-small Cell Lung Cancers and Gastro-intestinal Cancers Harboring KRAS G12C Mutations
Clinical trial NCT05848843 · WITHDRAWN
Trial details
- NCT number
- NCT05848843
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-25
- Primary completion
- 2024-01-16
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.